Major investment in groundbreaking programme to speed up cancer diagnosis in Wales
A major £2.52 million investment will accelerate the use of cutting-edge liquid biopsy technology that analyses cancer DNA from a blood sample, supporting faster and more personalised treatment decisions.
12 December 2025
First patient recruited in clinical trial using cancer-targeting virus
Accession Therapeutics’ ATTEST trial is a first-in-human Phase 1 trial in solid tumour patients, testing TROCEPT-01 (also known as ATTR-01). The trial is being delivered by Velindre University NHS Trust and Cardiff and Vale University Health Board.
9 December 2025
Emma Williams becomes first nurse in CRUK Women of Influence programme
Emma Williams, Senior Research Nurse Manager at the Velindre Cancer Service, has become the first nurse to be accepted onto the Cancer Research UK Women in Influence programme.
9 December 2025
Cardiff's leading health partners unite to improve benefits for patients
Cardiff Health Partners (CHP) will see Cardiff University, Cardiff and Vale University Health Board and Velindre University NHS Trust come together formally to strengthen healthcare delivery, foster research excellence, economic growth, and social wellbeing across the capital and wider South East Wales region.
1 December 2025
Palliative Care Virtual Reality Research Project
A research study into the use of virtual reality (VR) headsets as a pain management method for patients with advanced cancer shows promise in preliminary informal results.
27 November 2025
Thoracic Oncology Trials Team Shortlisted for Oncology Team of the Year
The Thoracic Oncology Trials Team at Velindre Cancer Centre have been selected as finalists for the ‘Oncology Team of the Year’ Award at the Welsh Healthcare Awards 2025.
25 September 2025
Cardiff Cancer Research Partnership (CCRP) launches in Cardiff
A celebration and launch event was held at Cardiff University's Hadyn Ellis Building to launch a new partnership between Cardiff University, Velindre University NHS Trust, and Cardiff and Vale University Health Board.
24 September 2024
Velindre opens research study to uncover the secrets of long-term cancer survivors
We launch the Rosalind Study in Wales, an international research initiative aimed at understanding the unique characteristics of people who beat the odds to survive aggressive cancer.
16 June 2025
Full circle at Velindre as first patient in Wales gets new breast cancer treatment
Barry resident Gwen Buchan has become the first person in Wales to receive a new breast cancer treatment that began its life as an idea and then clinical trials at Velindre Cancer Service 10 years ago.
31 May 2025
Collaborating for success on International Clinical Trials Day
Collaboration is key to the success of any clinical trial and on International Clinical Trials Day, 20 May 2025 we are shining a spotlight on the way we work together to deliver the innovative clinical trials that Velindre is known for.
20 May 2025
Velindre research leads to NICE approved treatment for NHS breast cancer patients
National Institute for Health and Care Excellence has announced today that a treatment for advanced breast cancer that started its life in Cardiff more than 10 years ago, has been approved for use by the NHS in England and Wales.
14 April 2025
First Welsh patient gets investigational vaccine against colorectal cancer
A Velindre patient has become the first person in Wales to receive an investigational vaccine designed to fight her own specific form of cancer, as part of a groundbreaking new research study.
4 February 2025
Study Published in Clinical Oncology Journal!
Dr Annabel Borley and Dr Sophie Harding have had their research on the Phesgo project published in the ‘Clinical Oncology’ journal.
16 December 2024
UK's first patients for Cardiff-led BICCC study
We are very proud to have recruited the first patients in the UK to BICCC, a new colorectal clinical trial aimed at increasing disease-free survival.
4 December 2024
Proton beam clinical trial first for Velindre
APPROACH is a clinical trial looking at proton beam therapy for people with a brain tumour called oligodendroglioma and is the first of its kind for brain tumours at Velindre.
12 November 2024
Cancer awareness for next generation of dentists
Bryan Webber is using his experience of cancer diagnosis, treatment and clinical trials to support the next generation of dentists.
5 July 2024
We pay tribute to long-time clinical trial patient and great friend to Velindre, Alan Buckle who sadly died recently.
20 June 2024
QuicDNA take home Moondance Cancer Award
The QuicDNA study, clinically lead by Dr Meissner and co-investigated by Professor Richard Adams and Dr Paul Shaw, Consultant Clinical Oncologists at the Cancer Centre, took home an award at the Moondance Cancer Awards.
14 June 2024
Brain Tumour Research Initiative provides new funding for research in Wales
Dr James Powell, Consultant Clinical Oncologist at Velindre Cancer Centre and Clinical Academic at the Wales Cancer Research Centre (WCRC), has been appointed Clinical Lead for the Brain Tumour Research Initiative (BATRI), a new brain tumour research fund established by Cancer Research Wales.
3 May 2024
Radiotherapy researchers leading the way with first commercial device trial
The SABRE trial involves the use of the SpaceOAR Vue system designed by Boston Scientific in patients being treated with radiotherapy for prostate cancer.
15 January 2024
FDA approval for breast cancer drug treatment developed at Velindre
It all started more than 10 years ago with three people in a room in Cardiff, talking about ways to improve outcomes in the world’s most common type of cancer – oestrogen receptor positive breast cancer.
11 December 2023
Velindre proud to be part of successful clinical trial
The results of INTERLACE trial mark the biggest cervical cancer drug advance in 20 years.
7 November 2023
PATHOS, a Velindre University NHS Trust and Cardiff University co-sponsored clinical trial, is a Phase III, international trial aiming to develop a kinder treatment for patients with head and neck cancer.
6 September 2023
Ground-breaking trial to treat brain tumours begins at Velindre
A major UK clinical trial to treat the most aggressive brain tumour has opened at the Velindre Cancer Centre. It will investigate whether combining cannabinoids and chemotherapy can help extend the lives of people diagnosed with recurrent glioblastoma.
31 August 2023
Patients encouraged to ask about clinical trials
This International Clinical Trials Day, we're encouraging our patients to find out more about the clinical trials available to them and consider taking part.
20 May 2023
New phase of breast cancer treatment trial provides fresh hope for patients with incurable disease
The research, carried out by Velindre University NHS Trust, in partnership with AstraZeneca and Cardiff University over 10 years was presented at the world renowned American Society of Clinical Oncology conference on 4 June in Chicago and published simultaneously in the prestigious Lancet Oncology journal.
21 September 2022
Cancer is easier to treat if it is diagnosed early. There is a need to improve screening pathways and develop new diagnostic technologies that reduce the impact on NHS resources whilst specifically detecting those with cancer at an earlier stage.
15 September 2021